| Epidemiology of complications and total treatment costs from diagnosis of Type 2 diabetes in Germany (ROSSO 4) S Martin, W Schramm, B Schneider, K Neeser, C Weber, V Lodwig, ... Experimental and clinical endocrinology & diabetes 115 (08), 495-501, 2007 | 74 | 2007 |
| Integrated personalized diabetes management improves glycemic control in patients with insulin-treated type 2 diabetes: results of the PDM-ProValue study program B Kulzer, W Daenschel, I Daenschel, W Schramm, D Messinger, ... diabetes research and clinical practice 144, 200-212, 2018 | 59 | 2018 |
| Screening of diabetic patients for microalbuminuria in primary care—The PROSIT-Project W Piehlmeier, R Renner, W Schramm, T Kimmerling, S Garbe, ... Experimental and clinical endocrinology & diabetes 107 (04), 244-251, 1999 | 43 | 1999 |
| Evaluating the ability of economic models of diabetes to simulate new cardiovascular outcomes trials: a report on the ninth mount hood diabetes challenge L Si, MS Willis, C Asseburg, A Nilsson, M Tew, PM Clarke, M Lamotte, ... Value in Health 23 (9), 1163-1170, 2020 | 37 | 2020 |
| Cost effectiveness of combination therapy with pioglitazone for type 2 diabetes mellitus from a German statutory healthcare perspective K Neeser, G Lübben, U Siebert, W Schramm Pharmacoeconomics 22, 321-341, 2004 | 35 | 2004 |
| The challenge of transparency and validation in health economic decision modelling: a view from Mount Hood S Kent, F Becker, T Feenstra, A Tran-Duy, I Schlackow, M Tew, P Zhang, ... Pharmacoeconomics 37, 1305-1312, 2019 | 33 | 2019 |
| Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most … K Neeser, T Szucs, JL Bulliard, G Bachmann, W Schramm Value in health 10 (1), 42-53, 2007 | 33 | 2007 |
| A method for using real world data in breast cancer modeling M Pobiruchin, S Bochum, UM Martens, M Kieser, W Schramm Journal of biomedical informatics 60, 385-394, 2016 | 31 | 2016 |
| Integrated personalized diabetes management (PDM) design of the ProValue studies: Prospective, cluster-randomized, controlled, intervention trials for evaluation of the … B Kulzer, W Daenschel, I Daenschel, EG Siegel, W Schramm, CG Parkin, ... Journal of diabetes science and technology 10 (3), 772-781, 2016 | 21 | 2016 |
| Opportunities and barriers to the development and use of open source health economic models: a survey XGLV Pouwels, CJ Sampson, RJG Arnold, MD Janodia, R Henderson, ... Value in health 25 (4), 473-479, 2022 | 16 | 2022 |
| Benefit of digital tools used for integrated personalized diabetes management: results from the PDM-ProValue study program L Heinemann, W Schramm, H Koenig, A Moritz, I Vesper, J Weissmann, ... Journal of diabetes science and technology 14 (2), 240-249, 2020 | 15 | 2020 |
| PROSIT Open Source Disease Models for Diabetes Mellitus. W Schramm, F Sailer, M Pobiruchin, C Weiss ICIMTH, 115-118, 2016 | 14 | 2016 |
| Economic value of tiotropium in the treatment of chronic obstructive pulmonary disease W Schramm, D Haake, A Brandt Praxis 94 (46), 1803-1810, 2005 | 14 | 2005 |
| Assessment of SARS-CoV-2 infection among healthcare workers of a German COVID-19 treatment center L Larribère, J Gordejeva, L Kuhnhenn, M Kurscheidt, M Pobiruchin, ... International Journal of Environmental Research and Public Health 18 (13), 7057, 2021 | 12 | 2021 |
| Prediction of 5-Year Survival with Data Mining Algorithms. F Sailer, M Pobiruchin, S Bochum, UM Martens, W Schramm ICIMTH, 75-78, 2015 | 10 | 2015 |
| Exploring structural uncertainty and impact of health state utility values on lifetime outcomes in diabetes economic simulation models: findings from the Ninth Mount Hood … M Tew, M Willis, C Asseburg, H Bennett, A Brennan, T Feenstra, J Gahn, ... Medical Decision Making 42 (5), 599-611, 2022 | 9 | 2022 |
| 35th annual meeting of the European Association for the Study of diabetes: Brussels, Belgium, 28 September–2 October 1999 A Melander, J Olsson, G Lindberg, A Salzman, T Howard, P Stang, ... Diabetologia 42, A1-A330, 1999 | 9 | 1999 |
| Digital diabetes self-management: a trilateral serial W Schramm Journal of Diabetes Science and Technology 12 (3), 709-711, 2018 | 8 | 2018 |
| Integrated personalized diabetes management (iPDM) in patients with insulin-treated T2DM: Results of the PDM-ProValue study program L Heinemann, I Daenschel, W Dänschel, D Messinger, W Schramm, ... 11th International Conference on Advanced Technologies & Treatments for …, 2018 | 7 | 2018 |
| Regionale Analyse der medikamentösen Behandlungsprävalenz und Arzneimitteltherapie von Diabetes mellitus in Deutschland T Willert, J Walker, W Schramm DMW-Deutsche Medizinische Wochenschrift 137 (46), 2363-2368, 2012 | 7 | 2012 |
